Evidence map›Paper›PMID 32814778›Full record

ArticleNature communications2020

The Rad53

Christopher Bruhn, Arta Ajazi, Elisa Ferrari, Michael Charles Lanz, Renaud Batrin, Ramveer Choudhary, Adhish Walvekar, Sunil Laxman, Maria Pia Longhese, Emmanuelle Fabre and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. The Rad53Nature communications · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Christopher BruhnThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139, Milan, Italy. christopher.bruhn@ifom.eu.ORCID http://orcid.org/0000-0001-6656-996X
Arta AjaziThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139, Milan, Italy.
Elisa FerrariThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139, Milan, Italy.
Michael Charles LanzDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, 14853, USA.
Renaud BatrinUniversité de Paris, Laboratoire Génomes, Biologie Cellulaire et Thérapeutiques, CNRS UMR7212, INSERM U944, Centre de Recherche St Louis, F-75010, Paris, France.
Ramveer ChoudharyThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139, Milan, Italy.
Adhish WalvekarInstitute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, Karnataka, 560065, India.
Sunil LaxmanInstitute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, Karnataka, 560065, India.ORCID http://orcid.org/0000-0002-0861-5080
Maria Pia LongheseDipartimento di Biotecnologie e Bioscienze, Università degli Studi di Milano-Bicocca, Edificio U3, Piazza della Scienza 2, 20126, Milan, Italy.ORCID http://orcid.org/0000-0003-1726-2034
Emmanuelle FabreUniversité de Paris, Laboratoire Génomes, Biologie Cellulaire et Thérapeutiques, CNRS UMR7212, INSERM U944, Centre de Recherche St Louis, F-75010, Paris, France.ORCID http://orcid.org/0000-0002-0009-4604
Marcus Bustamente SmolkaDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, 14853, USA.ORCID http://orcid.org/0000-0001-9952-2885
Marco FoianiThe FIRC Institute of Molecular Oncology (IFOM), Via Adamello 16, 20139, Milan, Italy. marco.foiani@ifom.eu.ORCID http://orcid.org/0000-0003-4795-834X
IFOM · ITCentre National de la Recherche Scientifique · FRCornell University · USInstitute for Stem Cell Biology and Regenerative Medicine · INUniversity of Milan · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The DNA damage response (DDR) coordinates DNA metabolism with nuclear and non-nuclear processes. The DDR kinase Rad53

Indexed as

AcetylationAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCheckpoint Kinase 2DNA DamageDNA RepairGene SilencingGlucoseHistone DeacetylasesHistonesIntracellular Signaling Peptides and ProteinsMutationPhosphorylationProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCheckpoint Kinase 2GlucoseHistone DeacetylasesHistonesIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesRAD53 protein, S cerevisiaeRPD3 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSerineSPT21 protein, S cerevisiaeTEL1 protein, S cerevisiaeTranscription Factors

Identifiers

PMID32814778
PMCPMC7438486
OpenAlexW3055928394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.